Commitment to Equity, Diversity and Inclusion
We are committed to cultivating a culture of equity, diversity, inclusion, and accessibility. We acknowledge and deeply respect the individual differences, lived experiences, expertise, and knowledge of those within our cluster. We welcome all contributions regardless of age, gender identity or sexual orientation, physical ability, race, religion, ancestry, or culture.
While most organizations have a language and process in place to embrace diversity and be more inclusive, effectively developing and implementing an equity, diversity, and inclusion (EDI) strategy that is truly operational—and not tokenistic—requires more than good intentions. We aim to develop and implement an effective plan by exploring courses and programs that focus on unity, cohesion, and mutual support, and create fair, equitable, and inclusive communities and workplaces.
Required EDI training for ImmunoE Members: EDI Foundations
EDI Committee
Purpose
The Equity, Diversity, and Inclusion (EDI) Committee of the Immunoengineering NSERC CREATE is established to advance a culture of inclusion, equity, and respect across all aspects of cluster activities—including research, training, mentorship, and knowledge translation. The Committee will work to ensure that the development and application of immunotherapies reflect and serve the diversity of our communities, and that participation in the cluster is equitable and inclusive for members of historically underrepresented groups.
Objectives
Upcoming EDI Events in the Community 2026
Frybread Power: The Significance of Indigenous Empowerment, Pride and Resilience
Please join us for this in-person, all-day event on Monday, September 21, 2026, from 9:00 am to 4:00 pm at Jack Poole Hall on the UBC Vancouver campus.
This Indigenous Speakers Series session features Dr. Evan Tlesla Adams and Mr. Joe Gallagher, members of the Tla’amin Nation. Dr. Adams is the Deputy Chief Medical Officer, Public Health at the First Nations Health Authority and host of the docuseries The Conversation. Mr. Gallagher is the Vice President, Indigenous Health and Cultural Safety at the Provincial Health Services Authority.
Learn about their journeys in storytelling, medicine, and health-system transformation, and how these experiences have shaped their vision for thriving Indigenous futures.
CTLT Indigenous Initiative Virtual Coffee Hour
We welcome you to attend one of CTLT Indigenous Initiatives’ monthly Virtual Coffee Hours. They are an informal space to connect with consultants on the team and other colleagues across the university. We are always excited to hear about a project you are working on or a new resource you found, peer-to-peer sharing is highly encouraged. Please come if you have questions or are just looking to say hello!
Past EDI Events
2025
Self-guided Tour of the Indian Residential School History and Dialogue Centre (IRSHDC)
Let's Talk EDI - Neuroinclusivity in Academia
This workshop, given by students and staff of the MBIM EDI Committee highlighted how we can provide a more inclusive space for neurodivergent people in academia. Through an interactive workshop, the committee worked with participants to brainstorm and suggest strategies to improve accessibility for neurodivergent trainees, creating a space where everyone can thrive in their education.
2024
EDI Workshop with Dr. Annie Ciernia
Interactive seminar given by Dr. Annie Ciernia highlighting the advances and shortcomings of equity in academic settings, including here at UBC. This workshop provided insight on where the current EDI initiatives at UBC are improving inclusivity in the academic space, and where we are still falling short on making this a welcoming space for all people, with emphasis on what more needs to be done moving forward.
Resources links
UBC Initiatives, events, and offices
Student resources:
Other resources:


Contact Information
General Inquiries:
immuno.therapeutics@ubc.ca
ImmunoE NSERC CREATE Program: immunoengineering.create@ubc.ca
6088 University Boulevard, Vancouver, BC V6T 1Z3



© Copyright 2025 by ImmunoT & ImmunoE